Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT02336633
Eligibility Criteria:
Inclusion criteria :
* Positive genetic test with CAG repeat length \> or = 39 in HTT gene
* At least 18 years of age
* Signature of the informed consent
* Covered by social security
* UHDRS score between 5 and 40 (both included)
* Ability to undergo MRI scanning
Exclusion criteria :
* Hypersensitivity to resveratrol or to one of its excipients (gelatin and glycerin)
* Tetrabenazine treatment
* Neuroleptic treatments other than olanzapine at small doses (≤10 mg) and Abilify® (≤15mg)
* VKA treatment (Previscan®, Sintron®, Coumadine®)
* NACO treatment (Pradaxa®, Xarelto®, Eliquis®)
* Additional psychiatric or neurological conditions
* Severe head injury
* Participation in another therapeutic trial (3 months exclusion period)
* Pregnancy and breastfeeding
* Inability to understand information about the protocol
* Persons deprived of their liberty by judicial or administrative decision
* Adult subject under legal protection or unable to consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02336633
Study Brief:
Protocol Section:
NCT02336633